LICCHETTA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 8.429
AS - Asia 8.019
EU - Europa 5.367
SA - Sud America 477
AF - Africa 399
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.714
Nazione #
US - Stati Uniti d'America 8.222
SG - Singapore 2.104
VN - Vietnam 2.058
CN - Cina 1.897
IT - Italia 1.459
GB - Regno Unito 962
DE - Germania 707
SE - Svezia 574
HK - Hong Kong 568
BR - Brasile 356
FR - Francia 321
BD - Bangladesh 313
IN - India 306
NL - Olanda 282
RU - Federazione Russa 241
KR - Corea 225
IE - Irlanda 183
UA - Ucraina 139
CA - Canada 137
JP - Giappone 134
FI - Finlandia 126
CI - Costa d'Avorio 115
ZA - Sudafrica 108
JO - Giordania 70
EE - Estonia 55
AT - Austria 50
BG - Bulgaria 50
AR - Argentina 49
TG - Togo 48
PH - Filippine 45
ID - Indonesia 43
CH - Svizzera 42
MX - Messico 42
SC - Seychelles 40
IQ - Iraq 39
ES - Italia 36
TR - Turchia 34
TH - Thailandia 31
PL - Polonia 30
PK - Pakistan 28
BE - Belgio 27
NG - Nigeria 26
UZ - Uzbekistan 22
EC - Ecuador 17
GR - Grecia 17
TW - Taiwan 17
SA - Arabia Saudita 16
CO - Colombia 15
AU - Australia 14
CL - Cile 12
MY - Malesia 12
PY - Paraguay 11
EG - Egitto 10
IL - Israele 9
MA - Marocco 9
RO - Romania 9
PT - Portogallo 8
TN - Tunisia 8
IR - Iran 7
KE - Kenya 7
LB - Libano 7
LT - Lituania 7
VE - Venezuela 7
HU - Ungheria 6
PE - Perù 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
JM - Giamaica 4
LV - Lettonia 4
NO - Norvegia 4
RS - Serbia 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CG - Congo 3
CM - Camerun 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
AL - Albania 2
GH - Ghana 2
KG - Kirghizistan 2
KH - Cambogia 2
MD - Moldavia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 22.687
Città #
Singapore 1.490
Ashburn 1.007
Southend 708
Fairfield 700
Hong Kong 546
Hefei 500
Chandler 498
Ho Chi Minh City 494
Hanoi 438
San Jose 405
Woodbridge 338
Seattle 325
Houston 318
Wilmington 293
Santa Clara 289
Cambridge 253
Beijing 241
Ann Arbor 237
Bologna 210
Seoul 210
Princeton 206
Dublin 182
Boardman 180
Council Bluffs 165
New York 151
Dallas 150
Lauterbourg 144
Los Angeles 143
Tokyo 122
Turin 117
Abidjan 115
Dong Ket 114
Milan 103
Helsinki 80
Redmond 79
Westminster 78
Munich 76
Jacksonville 74
Rome 74
Nanjing 70
Amman 69
Berlin 69
Florence 69
Buffalo 68
Montréal 67
Redondo Beach 65
Haiphong 63
Da Nang 61
Frankfurt am Main 57
Padova 57
Sofia 49
São Paulo 49
Lomé 48
Saint Petersburg 48
Mcallen 46
Amsterdam 44
Chicago 43
Jinan 43
Bengaluru 42
Modena 42
Nuremberg 42
Shanghai 41
London 38
Naples 36
San Diego 36
Lappeenranta 33
Shenyang 33
Bern 32
Orem 32
Vienna 32
Hải Dương 30
Biên Hòa 29
Guangzhou 28
Johannesburg 28
Jakarta 27
Changsha 26
Nanchang 26
Tianjin 25
Castel Maggiore 24
Falls Church 24
Thái Nguyên 24
Brussels 23
Abeokuta 22
Can Tho 22
Phoenix 22
Zhengzhou 22
Dearborn 21
Warsaw 21
Atlanta 20
Des Moines 20
Düsseldorf 20
Toronto 20
Mülheim 19
Brooklyn 18
Lahore 18
Medford 18
Redwood City 18
Rimini 18
Falkenstein 17
Paris 17
Totale 14.044
Nome #
Clinical features and pathophysiology of disorders of arousal in adults: A window into the sleeping brain 478
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 398
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 323
Clinical characterization of non-ketotic hyperglycemia-related seizures: A systematic review and individual participant data meta-analysis 266
LGI1 microdeletions are not a frequent cause of partial epilepsy with auditory features (PEAF). 255
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 250
Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies 245
A seizure response dog: video recording of reacting behaviour during repetitive prolonged seizures. 237
Auditory aura in nocturnal frontal lobe epilepsy: a red flag to suspect an extra-frontal epileptogenic zone 233
Autosomal dominant partial epilepsy with auditory features: A new locus on chromosome 19q13.11-q13.31. 229
Accurate Detection of Hot-Spot MTOR Somatic Mutations in Archival Surgical Specimens of Focal Cortical Dysplasia by Molecular Inversion Probes 229
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 227
Profile of neuropsychological impairment in Sleep-related Hypermotor Epilepsy 225
Cerebral areas involved in music perception: studying musicogenic epilepsy. 215
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 211
GATOR1 complex: the common genetic actor in focal epilepsies 210
Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy 208
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 208
PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy 206
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 206
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 205
Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy 204
Epilepsy with auditory features: Contribution of known genes in 112 patients 204
Epilepsy With Auditory Features: From Etiology to Treatment 202
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy 200
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 198
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. 196
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 196
Response to the letter "New avenues to prevent sudden unexpected death in nocturnal frontal lobe epilepsy: follow the route established by omega-3 polyunsaturated fatty acids". 193
Definition and diagnostic criteria of sleep-related hypermotor epilepsy 193
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 191
Epilepsy with auditory features: A heterogeneous clinico-molecular disease 190
FDG-PET assessment and metabolic patterns in Lafora disease 189
Ictal vasodepressive syncope in temporal lobe epilepsy 187
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 187
Phenotype variability of GLUT1 deficiency syndrome: Description of a case series with novel SLC2A1 gene mutations 186
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 185
Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy 185
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 181
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 181
Specific motor patterns of arousal disorders in adults: A video-polysomnographic analysis of 184 episodes 179
Seizures with paroxysmal arousals in sleep-related hypermotor epilepsy (SHE): Dissecting epilepsy from NREM parasomnias 177
Prevalence of Nocturnal Frontal Lobe Epilepsy in the Adult Population of Bologna and Modena, Emilia-Romagna Region, Italy. 176
Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late 175
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 173
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 172
Sleep-related hypermotor epilepsy (SHE): Contribution of known genes in 103 patients 171
Treatment with metformin in twelve patients with Lafora disease 171
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. 170
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 169
Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? 169
Cortical myoclonic tremor induced by fixation-off sensitivity: An unusual cause of insomnia 168
Neuropsychological impairment in patients with early onset nocturnal frontal lobe epilepsy. 166
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 166
Epilepsy in ring chromosome 20 syndrome 166
Proton MR spectroscopy in patients with sleep-related hypermotor epilepsy (SHE): Evidence of altered cingulate cortex metabolism 165
Epilepsy and inborn errors of metabolism in adults: The diagnostic odyssey of a young woman with medium-chain acyl-coenzyme A dehydrogenase deficiency 164
Epilepsy in coeliac disease: not just a matter of calcifications. 163
Complete Agenesis of Corpus Callosum in KCNQ2-Related Neonatal Epileptic Encephalopathy 162
Nocturnal motor behaviors with unexpected EEG and brain MRI findings 162
Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep 161
Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. 160
Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study 158
Health-related quality of life in patients with Nocturnal Frontal Lobe Epilepsy. 155
Extended Glasgow Outcome Scale to Evaluate the Functional Impairment of Patients With Subcortical Band Heterotopia: A Multicentric Cross-sectional Study 153
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 151
Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2 151
Epilepsy with eyelid myoclonias and Sotos syndrome features in a patient with compound heterozygous missense variants in APC2 gene 151
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. 150
Progressive myoclonic epilepsies: definitive and still undetermined causes 150
Limbic encephalitis with anti-GAD antibodies and Thomsen myotonia: A casual or causal association? 149
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series 148
A Novel Mutation af Cln3 Associated with Delayed-Classic Juvenile Ceroid Lipofucinois and Autophagic Vacuolar Myopathy 148
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 147
Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients 146
Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2–2q11.2 146
Neuropsychological assessment in patients with early onset nocturnal frontal lobe epilepsy. 146
Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease) 146
If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol 146
Therapy in Sleep-Related Hypermotor Epilepsy (SHE) 145
Progressive Myoclonus Epilepsies Diagnostic Yield with Next-Generation Sequencing in Previously Unsolved Cases 145
Tobacco habits in nocturnal frontal lobe epilepsy 142
Polygenic burden in focal and generalized epilepsies 142
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 141
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. 141
Pseudohyperkalemia due to cryohydrocytosis in GLUT1 deficiency syndrome. A case report and literature review 140
VAL-1221 for the treatment of patients with Lafora disease: Study protocol for a single-arm, open-label clinical trial 139
Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report 139
MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution 137
A stereo EEG study in a patient with sleep-related hypermotor epilepsy due to DEPDC5 mutation 137
The landscape of epilepsy-related GATOR1 variants 136
Epilepsy with Bilateral Hippocampal Hyperintensity and Celiac Disease: Comorbidity or a real association? 135
DEPDC5 mutations in epilepsy with auditory features 134
Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K(+) channel properties 134
SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus 133
Mutations in DEPDC5 cause familial focal epilepsy with variable foci. 131
Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations 130
Identification of genes responsible for Nocturnal Frontal Lobe Epilepsy (NFLE): role of DEPDC5 mutations 129
A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsies 129
Estrogen-related seizure exacerbation following hormone therapy for assisted reproduction in women with epilepsy 127
Totale 18.024
Categoria #
all - tutte 61.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021360 0 0 0 0 0 0 0 0 0 0 0 360
2021/20222.119 164 62 111 206 191 104 57 147 109 265 402 301
2022/20232.300 227 290 105 254 175 165 78 117 409 104 281 95
2023/2024821 56 118 54 100 59 147 31 71 31 68 36 50
2024/20253.197 96 458 209 244 394 134 155 103 49 342 212 801
2025/20269.924 1.073 1.022 819 820 873 446 953 343 1.634 737 575 629
Totale 23.272